BAFF BINDING INHIBITOR HAVING 4-(2-BENZYLIDENE HYDRAZINYL)-2-PHENYLPYRIMIDINE DERIVATIVE AS ACTIVE INGREDIENT

摘要

PROBLEM TO BE SOLVED: To provide a drug which inhibits the BAFF binding to a BR3 receptor and has excellent preventing and treating effects on autoimmune diseases, acquired immunodeficiency syndrome, and non-Hodgkin lymphoma.;SOLUTION: The BAFF binding inhibitor to a BR3 receptor includes a compound represented by formula (1) (wherein R¹ is a 1-10C alkyl group; and R², R³, R⁴, and R⁵ may be the same as or different from one another and are each hydrogen or a hydroxyl group), a salt thereof or a solvate thereof as an active ingredient.;COPYRIGHT: (C)2012,JPO&INPIT